Why have ovarian cancer mortality rates declined? Part II. Case-fatality Article

Sopik, Victoria, Iqbal, Javaid, Rosen, Barry et al. (2015). Why have ovarian cancer mortality rates declined? Part II. Case-fatality . GYNECOLOGIC ONCOLOGY, 138(3), 750-756. 10.1016/j.ygyno.2015.06.016

cited authors

  • Sopik, Victoria; Iqbal, Javaid; Rosen, Barry; Narod, Steven A

sustainable development goals

authors

publication date

  • September 1, 2015

published in

keywords

  • ADVANCED EPITHELIAL OVARIAN
  • ADVANCED-STAGE OVARIAN
  • COMBINATION CHEMOTHERAPY
  • HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY
  • LONG-TERM SURVIVAL
  • Life Sciences & Biomedicine
  • Mortality
  • NEOADJUVANT CHEMOTHERAPY
  • ONCOLOGY-GROUP
  • Obstetrics & Gynecology
  • Oncology
  • Ovarian cancer
  • PERITONEAL CANCER
  • PRIMARY DEBULKING SURGERY
  • PROGNOSTIC-FACTORS
  • Science & Technology

Digital Object Identifier (DOI)

publisher

  • ACADEMIC PRESS INC ELSEVIER SCIENCE

start page

  • 750

end page

  • 756

volume

  • 138

issue

  • 3